Agilent Technologies, Inc. $A Shares Acquired by Lmcg Investments LLC

Lmcg Investments LLC increased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 13.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 82,905 shares of the medical research company’s stock after acquiring an additional 9,911 shares during the quarter. Lmcg Investments LLC’s holdings in Agilent Technologies were worth $10,641,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Norges Bank purchased a new position in shares of Agilent Technologies during the second quarter worth $395,088,000. AQR Capital Management LLC increased its position in shares of Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after purchasing an additional 1,652,244 shares during the last quarter. Ameriprise Financial Inc. raised its holdings in shares of Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after purchasing an additional 1,340,161 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in shares of Agilent Technologies by 10.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock valued at $1,560,964,000 after purchasing an additional 1,273,994 shares in the last quarter. Finally, Troy Asset Management Ltd lifted its position in shares of Agilent Technologies by 74.3% during the 2nd quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock worth $282,967,000 after purchasing an additional 1,021,865 shares during the last quarter.

Agilent Technologies Price Performance

Shares of A opened at $139.68 on Friday. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $160.27. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. The company has a market cap of $39.60 billion, a P/E ratio of 30.56, a PEG ratio of 4.05 and a beta of 1.29. The stock has a fifty day moving average price of $144.41 and a 200 day moving average price of $133.45.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. The business had revenue of $1.86 billion for the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The company’s revenue was up 9.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th will be issued a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, January 6th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s payout ratio is presently 22.32%.

Analyst Ratings Changes

A has been the topic of several recent analyst reports. Rothschild & Co Redburn assumed coverage on Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price on the stock. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Evercore ISI upgraded shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and increased their price target for the company from $155.00 to $160.00 in a research note on Monday, January 5th. Finally, Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $163.31.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 12,490 shares of Agilent Technologies stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the transaction, the chief executive officer directly owned 33,448 shares in the company, valued at $5,017,200. The trade was a 27.19% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total value of $464,970.00. Following the sale, the vice president directly owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 16,401 shares of company stock worth $2,468,962 in the last ninety days.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.